Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study
Year: 2013
Type: article
Study design: Observational Study
Abstract: UNLABELLED: Primary biliary cirrhosis (PBC) has a complex clinical phenotype, with debate about the extent and specificity of frequently described systemic symptoms such as fatigue. The aim of this study was to use a national patient cohort of 2,353 patients recruited from all clinical centers in the UK to explore the impact of disease on perceived life quality. Clinical data regarding diagnosis, therapy, and biochemical status were collected and have been reported previously. Detailed symptom phenotyping using recognized and validated symptom assessment tools including the PBC-40 was also undertaken and is reported here. Perception of poor quality of life and impaired health status was common in PBC patients (35% and 46%, respectively) and more common than in an age-matched and sex-matched community control group (6% and 15%, P < 0.0001 for both). Fatigue and symptoms of social dysfunction were associated with impaired perceived quality of life using multivariate analysis. Fatigue was the symptom with the greatest impact. Depression was a significant factor, but appeared to be a manifestation of complex symptom burden rather than a primary event. Fatigue had its greatest impact on perceived quality of life when accompanied by symptoms of social dysfunction, suggesting that maintenance of social networks is critical for minimizing the impact of fatigue. CONCLUSION: The symptom burden in PBC, which is unrelated to disease severity or ursodeoxycholic acid response, is significant and complex and results in significant quality of life deficit. The complexity of symptom burden, and its lack of relation to disease severity and treatment response, suggest that specific approaches to symptom management are warranted that address both symptom biology and social impact.
Source: Hepatology
DOI: 10.1002/hep.26365
Institutions: University of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Newcastle University, NIHR Newcastle Biomedical Research Centre, Edinburgh Royal Infirmary, The Royal Free Hospital, University College London, King's College Hospital NHS Foundation Trust, Queen Elizabeth Hospital Birmingham
Language: English
Topic: Liver Diseases and Immunity
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Royal Devon and Exeter NHS Foundation Trust, Wellcome Trust, NHS Greater Glasgow and Clyde, Sandwell and West Birmingham Hospitals NHS Trust, Nottingham University Hospitals NHS Trust, University Hospitals Bristol NHS Foundation Trust, University Hospitals of Leicester NHS Trust, Heart of England NHS Foundation Trust, Royal Free London NHS Foundation Trust, University Hospitals Plymouth NHS Trust, National Institute for Health and Care Research, University of Cambridge, University of Southampton, Imperial College London, Imperial College Healthcare NHS Trust, University College London, Chelsea and Westminster Hospital NHS Foundation Trust, Newcastle University, University of Nottingham, Cambridge University Hospitals, Newcastle upon Tyne Hospitals NHS Foundation Trust, Isaac Newton Trust, North Bristol NHS Trust, University College London Hospitals NHS Foundation Trust, Norfolk and Norwich University Hospitals NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, University Hospitals Coventry and Warwickshire NHS Trust, Medical Research Council, Guy's and St Thomas' NHS Foundation Trust, NIHR Newcastle Biomedical Research Centre
OpenAlex ID: W2093292173
